The Effect of Gut Microbiota on the Progression of Intervertebral Disc Degeneration

Bo Yao1, Youquan Cai1, Weiguo Wang2

  • 1Department of Spine Surgery, Want want hospital, Changsha, Hunan, China.

Orthopaedic Surgery
|January 5, 2023
PubMed
Abstract

Insights

Fecal microbiota transplantation (FMT) shows promise for treating intervertebral disc degeneration (IDD). FMT improved cellular stability and reduced tissue damage in a rat model, positively impacting gut microbiota diversity.

Area of Science:

  • Biomedical Science
  • Microbiology
  • Orthopedics

Background:

  • Intervertebral disc degeneration (IDD) is a primary cause of back pain, posing a significant socio-economic challenge.
  • Fecal microbiota transplantation (FMT) is an established therapeutic approach, but its role in IDD remains unexplored.

Purpose of the Study:

  • To investigate the potential therapeutic effects of FMT on IDD.
  • To elucidate the relationship between gut microbiota and IDD.

Main Methods:

  • An experimental rat model of IDD was established.
  • FMT was administered via intragastric gavage.
  • Biochemical markers, histopathology, and gut microbiota composition (16S rRNA sequencing) were analyzed.

Main Results:

  • IDD induced increased inflammatory markers (TNF-α, IL-1β, IL-6) and matrix-degrading enzymes (MMP-3, MMP-13), with decreased structural proteins (Collagen II, aggrecan).
  • FMT intervention reversed these molecular changes and alleviated histopathological damage in vertebral discs.
  • FMT treatment enhanced gut microbiota diversity and abundance in IDD model rats.

Conclusions:

  • FMT demonstrates a positive effect on maintaining vertebral disc cellular stability and mitigating histopathological damage.
  • FMT influences the gut microbiota composition in rats with IDD.
  • Fecal microbiota transplantation emerges as a potential therapeutic target for ameliorating intervertebral disc degeneration.